Highest-materiality recent filing
Cardlytics receives Nasdaq deficiency notice; implements 1-for-10 reverse stock split
Nasdaq notified CDLX that bid price closed below $1 for 30 consecutive days; 180-day cure period ends Nov 30, 2026.
Cardlytics stockholders approve reverse stock split authorization at annual meeting
All three Class II director nominees elected: Amit Gupta, Jack Klinck, Shrishti Gupta.
Cardlytics Chief Legal & Privacy Officer Nick Lynton to resign; receives $380K+ severance
Nick Lynton resigns as Chief Legal & Privacy Officer, effective July 3, 2026 or upon successor appointment.
Cardlytics Q1 revenue $34.3M (-39% YoY); net loss narrows to $4.5M; adj EBITDA positive $0.2M
Revenue $34.3M, down 39% YoY from $56.4M; net loss $(4.5)M ($0.08/share) vs $(13.3)M ($0.26) in Q1 2025.
Cardlytics completes sale of Bridg platform to PAR Technology for 1.81M PAR shares
Closed Bridg asset sale to PAR on March 24, 2026; consideration of 1,810,222 shares of PAR common stock.
Cardlytics Q4 revenue $56.1M (-24% YoY), losses narrow; Q1 guidance weak
Q4 revenue $56.1M, down 24.2% YoY; billings $94.1M, down 19%.
Cardlytics agrees to sell Bridg platform to PAR Technology for up to $30M in stock
PAR acquires all Bridg platform assets; purchase consideration up to $30M in PAR common stock.
Cardlytics appoints David Evans as CFO effective Jan 12, 2026; returning alumnus
David Evans appointed CFO effective Jan 12, 2026; previously served as Cardlytics CFO (2016-2020) and led 2018 IPO.
CFO Alexis DeSieno to resign; successor search underway
CFO DeSieno notified resignation on Dec 3, 2025; effective upon successor or Mar 6, 2026.
Cardlytics Q3 revenue $52M (-22% YoY); net loss $72.7M, adj EBITDA positive $3.2M
Revenue $52.0M, down 22% YoY; net loss $72.7M ($1.36/share) improved from $145.2M loss in Q3 2024.
Cardlytics cuts ~120 employees (30% workforce) in cost-savings plan
Reducing workforce by ~120 employees and contractors (30% of total).
Cardlytics Q2 revenue down 9% YoY to $63.2M; net loss widens; Q3 guidance weak
Revenue $63.2M, -9% YoY; billings $104M, -6%; adjusted contribution $36.1M, -1%.
Cardlytics extends JPMorgan Chase Master Agreement to Nov 2028; revenue share changes Jan 2026
Fourth Amendment extends Master Agreement term with JPMorgan Chase to November 18, 2028.
Cardlytics CEO Gupta gets 1.2M shares in RSUs/PSUs, enhanced severance
CEO Amit Gupta granted 1,000,000 RSUs vesting over 2 years from June 23, 2025 (50% at year 1, remainder quarterly).
Cardlytics shareholders approve 2025 Equity Incentive Plan authorizing up to 15.7M shares
Plan authorizes 15,722,908 shares: 10M new shares plus prior plan reserves and returning shares.
Cardlytics Q1 revenue down 8% to $61.9M; net loss narrows; Q2 guidance mixed
Revenue $61.9M (-8% YoY); net loss $(13.3M) vs $(24.3M) prior year.
Cardlytics receives Bank of America non-renewal for offer agreement; extends loan to 2028
Bank of America sent non-renewal notice; agreements expire July 31, 2025.
Cardlytics Q4 revenue down 17% YoY to $74.0M; guides Q1 2025 EBITDA loss
Q4 total revenue $74.0M, down 17% YoY; net loss $15.6M ($0.31 loss/share) vs $100.8M loss in Q4 2023.
Cardlytics Q3 revenue $67.1M beats high end of guide; net loss $145.2M; Q4 outlook soft
Revenue $67.1M, down 15% YoY (13% ex Entertainment); beat high end of guidance.
Cardlytics appoints Srishti Gupta to board of directors
Gupta, age 45, is Chief Product Officer at Integral Ad Science; previously CPO at Rokt and director at Amazon.
Cardlytics enters amended loan agreement with Banc of California; terms unchanged
Entered amended loan agreement with Banc of California (successor to Pacific Western Bank) on Sept 30, 2024.
Cardlytics appoints Amit Gupta CEO; details $550K salary, 1M+ RSUs
Karim Temsamani resigned as CEO and board member effective August 16, 2024; no disagreement cited.
Cardlytics Q2 revenue down 9% to $69.6M, CEO Temsamani resigns, Gupta appointed
Q2 2024: Revenue $69.6M (-9% YoY); net loss $4.3M vs $23.5M loss YoY; adjusted EBITDA loss $2.3M.
Quorum of 74.12% (35,710,280 of 48,173,734 shares outstanding) present at May 23, 2024 annual meeting.
Cardlytics Q1 revenue up 5% to $67.6M, adjusted EBITDA turns positive at $0.2M
Revenue $67.6M (+5% YoY, +8% ex Entertainment); net loss $(24.3)M vs net income $13.6M prior year.
Cardlytics appoints Liane Hornsey to Board of Directors
Liane Hornsey appointed to Board and Compensation Committee, effective April 9, 2024.
Cardlytics issues $172.5M of 4.25% convertible notes due 2029, repurchases $183.9M of 2025 notes
Issued $172.5M principal of 4.25% convertible senior notes due 2029, including full exercise of $22.5M initial purchasers' option.
Cardlytics enters $50M at-the-market offering agreement with Evercore, BofA, Cantor
Equity Distribution Agreement for up to $50M of common stock, filed March 18, 2024.
Cardlytics completes $50M at-the-market offering, selling 3.9M shares at $12.80
Sold 3,907,600 shares at weighted avg price of $12.80 for gross proceeds of $50.0M.
Cardlytics Q4 revenue $89.2M (+8.1% YoY); first full-year positive Adjusted EBITDA since 2019
Q4 revenue $89.2M (+8.1% YoY); full-year revenue $309.2M (+3.6% YoY).
Cardlytics enters marketing platform agreement with American Express
Cardlytics will make its proprietary marketing platform available to American Express for card-linked offers to certain cardmembers.
Settlement with SRS resolves all Bridg earnout disputes; total value ~$46M based on stock price at market close Jan 26.
Andre Fernandez (ex-WeWork CFO) and Jon Francis (GM Chief Data & Analytics Officer) join Cardlytics board effective Jan 1, 2024.
Cardlytics renews Lloyds Bank spending rewards agreement through Dec 2026
Cardlytics UK renewed spending rewards agreement with Lloyds Bank Plc through December 31, 2026.
Cardlytics Q3 revenue up 9% to $79M, net loss $(0.63)/share, adj. EBITDA turns positive $3.9M
Revenue $79.0M (+9% YoY); net loss $(24.0)M or $(0.63) per diluted share vs net income $6.3M in Q3 2022.
Tony Weisman resigns from Cardlytics Board and committees effective Oct 24
Tony Weisman resigned as director and member of the nominating and corporate governance committee on October 24, 2023.
Cardlytics appoints Alex Mishurov to board under cooperation agreement with CAS Investment Partners
Alex Mishurov appointed as Class I director effective immediately; term expires at 2025 annual meeting.
Cardlytics appoints former ICE CFO Scott Hill to Board of Directors
Scott Hill appointed as Class I director effective September 5, 2023, and joins Audit Committee.
Cardlytics Q2 net loss narrows to $23.5M; revenue up 2% YoY to $76.7M
Revenue $76.7M (+2% YoY); gross profit $30.5M (+13% YoY).
Cardlytics appoints Alexis DeSieno as CFO effective August 14, 2023
Alexis DeSieno named CFO, effective Aug 14, 2023; replaces outgoing CFO Andrew Christiansen.
Director Christopher Suh resigns from Cardlytics board to become Visa CFO
Christopher Suh resigned from Board and Audit Committee effective July 10, 2023.
Cardlytics amends JPMorgan agreement; supplier billings share increased through Nov 2025
Entered Third Amendment to Master Agreement with JPMorgan Chase Bank on June 29, 2023.
Cardlytics annual meeting results; say-on-pay passes with 48% against votes
Elected Class II directors Temsamani, Klinck, Weisman; votes 19.5M, 17.1M, 12.1M for respectively.
Cardlytics Q1 revenue $64.3M (-5% YoY); non-GAAP net loss narrows; CFO implies succession
Revenue $64.3M (-5% YoY); GAAP net income $13.6M ($0.40 diluted) vs $33.0M ($0.91) last year.
Cardlytics Bridg earnout set at $208M; cash/stock payment due
Independent Accountant set First Anniversary ARR at $23.2M, triggering $208.1M earnout payment.
Cardlytics raises Q1 2023 guidance: revenue $63.5-66.5M, Adj EBITDA loss narrows to $5-8M
Billings guidance raised to $93-97M from $84-93M; revenue to $63.5-66.5M from $54-63M.
Cardlytics CFO Andrew Christiansen to resign effective July 21, 2023
CFO Andrew Christiansen informed the company on March 17, 2023, of his intent to resign, effective July 21, 2023.
Cardlytics borrows $30M under $60M line of credit from Pacific Western Bank
Borrowed $30.0 million on March 13, 2023, under the existing $60 million revolving line of credit with Pacific Western Bank.
Cardlytics Q4 revenue down 8.4% to $82.5M; GAAP net loss $378.3M, guides Q1 weak
Q4 revenue $82.5M (-8.4% YoY); net loss $(378.3)M or $(11.32)/diluted share vs $(0.35) in Q4 2021.
Cardlytics appoints Amit Gupta as COO with $350k salary and 350k RSU grant
Appoints Amit Gupta as COO effective Jan 23, 2023; he will oversee operations, strategy, and business analytics.
On May 10, 2026, Nick Lynton, Chief Legal and Privacy Officer of Cardlytics, Inc. (the “Company”), notified the Company of his intent to resign from such position, effective as of the earlier of the appointment of his successor or the close of business on July 3, 2026 (the “Effective Date”).
On October 30, 2024, the board of directors (the “Board”) of Cardlytics, Inc. (the “Company”) appointed Srishti Gupta to serve as a director of the Company
On August 5, 2024, Karim Temsamani notified the Company of his intent to resign as the Company’s Chief Executive Officer and as a member of the Board of Directors of the Company (the “Board”), each effective as of August 16, 2024.
On August 7, 2024, the Board approved the appointment of Amit Gupta, currently the Company’s Chief Operating Officer, as the Company’s Chief Executive Officer and principal executive officer, each effective as of the Effective Date.
the Board also approved the appointment of Mr. Gupta to the Board, effective as of the Effective Date.
the Board also approved the appointment of Mr. Gupta to the Board, effective as of the Effective Date.
Karim Temsamani notified the Company of his intent to resign as the Company’s Chief Executive Officer and as a member of the Board of Directors of the Company (the “Board”), each effective as of August 16, 2024
the Board approved the appointment of Amit Gupta, currently the Company’s Chief Operating Officer, as the Company’s Chief Executive Officer and principal executive officer, each effective as of the Effective Date.
On April 9, 2024, the board of directors (the “Board”) of Cardlytics, Inc. (the “Company”) appointed Liane Hornsey to serve as a director of the Company and as a member of the compensation committee of the Board (the “Compensation Committee”).
On January 1, 2024, the Board appointed Jon Francis to serve as a director of the Company.
On January 1, 2024, the board of directors (the “Board”) of Cardlytics, Inc. (the “Company”) appointed Andre Fernandez to serve as a director of the Company and as a member of the audit committee of the Board (“Audit Committee”).
On October 24, 2023, Tony Weisman provided notice to the board of directors (the “Board”) of Cardlytics, Inc. (the “Company”) that he was resigning as member of the Board and as a member of the nominating and corporate governance committee of the Board, effective immediately.
Max materiality 0.85 · Median 0.65 · Most common event leadership